Rosemary C. McFall

1.1k citations

23 papers · 880 indexed · h-index 15

Impact in

Ophthalmology top 5%
- Ocular Oncology and Treatments
Cancer Research
- Protease and Inhibitor Mechanisms

Papers in

Oncology 11
- Cancer Treatment and Pharmacology 8
- HER2/EGFR in Cancer Research 7
Cancer Research 5
- Cancer, Hypoxia, and Metabolism 3

Co-authors: Christopher Reilly Theodore W. Sery Kathleen Coll Kenneth A. Thomas William F. Hoffman William R. Huckle Mark E. Fraley Leila Diamond
Journals: Bioorganic & Medicinal Chemistry Letters (7 papers)Circulation (2 papers)Molecular Cancer Therapeutics (1 paper)British Journal of Ophthalmology (1 paper)Current Medicinal Chemistry (1 paper)
Partner nations: United States

In The Last Decade

Rosemary C. McFall

22 papers receiving 837 citations

Peers

Countries citing papers authored by Rosemary C. McFall

Since Specialization

Citations

This map shows the geographic impact of Rosemary C. McFall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary C. McFall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary C. McFall more than expected).

Fields of papers citing papers by Rosemary C. McFall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary C. McFall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary C. McFall. The network helps show where Rosemary C. McFall may publish in the future.

Co-authors

The 25 scholars most cited alongside Rosemary C. McFall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rosemary C. McFall Line = papers co-authored together Rosemary C. McFall links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immunohistochemical Detection of Antitumor, Antimetastasis, and Antiangiogenesis Effects of a Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor in an Orthotopic Breast Cancer Metastasis Model Journal of Histotechnology ·Bin Shi, James C.H. Hardwick, Brett Connolly, Xianzhi Mao, Rosemary C. McFall, Susan L. Hill, Kenneth A. Thomas, Nancy E. Kohl, Laura Sepp‐Lorenzino	2010	0
2	Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling Molecular Cancer Therapeutics ·James S. Hardwick, Yi Yang, Chunsheng Zhang, Bin Shi, Rosemary C. McFall, Elizabeth J. Koury, Susan L. Hill, Hongyue Dai, Robert Wasserman, Robert L. Phillips, Edward J. Weinstein, Nancy E. Kohl, Michael E. Severino, John Lamb, Laura Sepp‐Lorenzino	2005	24
3	The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase Bioorganic & Medicinal Chemistry Letters ·Mark T. Bilodeau, Leonard D. Rodman, Georgia B. McGaughey, Kathleen Coll, Timothy J. Koester, William F. Hoffman, Randall W. Hungate, Richard Kendall, Rosemary C. McFall, Keith Rickert, Ruth Z. Rutledge, Kenneth A. Thomas	2004	27
4	Property-Based Design of KDR Kinase Inhibitors Current Medicinal Chemistry ·Mark E. Fraley, William F. Hoffman, Kenneth L. Arrington, Randy W. Hungate, George D. Hartman, Rosemary C. McFall, Kathleen Coll, Keith Rickert, Kenneth A. Thomas, Georgia B. McGaughey	2004	24
5	Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDR Bioorganic & Medicinal Chemistry Letters ·Mark T. Bilodeau, April M. Cunningham, Timothy J. Koester, Patrice A. Ciecko, Kathleen Coll, William R. Huckle, Randall W. Hungate, Richard Kendall, Rosemary C. McFall, Xianzhi Mao, Ruth Z. Rutledge, Kenneth A. Thomas	2003	13
6	2,4-Disubstituted pyrimidines: A novel class of KDR kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Peter J. Manley, Adrienne E. Balitza, Mark T. Bilodeau, Kathleen Coll, George D. Hartman, Rosemary C. McFall, Keith Rickert, Leonard D. Rodman, Kenneth A. Thomas	2003	23
7	Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Mark E. Fraley, Kenneth L. Arrington, Carolyn A. Buser, Patrice A. Ciecko, Kathleen Coll, Christine Fernandes, George D. Hartman, William F. Hoffman, Joseph J. Lynch, Rosemary C. McFall, Keith Rickert, Romi Singh, Sheri Smith, Kenneth A. Thomas, Bradley K. Wong	2003	43
8	2,4‐Disubstituted Pyrimidines: A Novel Class of KDR Kinase Inhibitors. ChemInform ·Peter J. Manley, Adrienne E. Balitza, Mark T. Bilodeau, Kathleen Coll, George D. Hartman, Rosemary C. McFall, Keith Rickert, Leonard D. Rodman, Kenneth A. Thomas	2003	1
9	Discovery and evaluation of 3-(5-Thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Mark E. Fraley, Kenneth L. Arrington, Scott R. Hambaugh, William F. Hoffman, April M. Cunningham, Mary Beth Young, Randall W. Hungate, Andrew J. Tebben, Ruth Z. Rutledge, Richard Kendall, William R. Huckle, Rosemary C. McFall, Kathleen Coll, Kenneth A. Thomas	2003	13
10	Synthesis and Initial SAR Studies of 3,6-Disubstituted Pyrazolo[1,5-a]pyrimidines: A New Class of KDR Kinase Inhibitors Bioorganic & Medicinal Chemistry Letters ·Mark E. Fraley, William F. Hoffman, Robert S. Rubino, Randall W. Hungate, Andrew J. Tebben, Ruth Z. Rutledge, Rosemary C. McFall, William R. Huckle, Richard Kendall, Kathleen Coll, Kenneth A. Thomas	2002	105
11	Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics Bioorganic & Medicinal Chemistry Letters ·Mark E. Fraley, Robert S. Rubino, William F. Hoffman, Scott R. Hambaugh, Kenneth L. Arrington, Randall W. Hungate, Mark T. Bilodeau, Andrew J. Tebben, Ruth Z. Rutledge, Richard Kendall, Rosemary C. McFall, William R. Huckle, Kathleen Coll, Kenneth A. Thomas	2002	79
12	Smooth muscle cells isolated from the neointima after vascular injury exhibit altered responses to platelet-derived growth factor and other stimuli Journal of Cellular Physiology ·R A Majack, Nicole A. Grieshaber, Colleen L. Cook, Mary C.M. Weiser, Rosemary C. McFall, Scott S. Grieshaber, M A Reidy, Christopher Reilly	1996	28
13	Pharmacological and mechanistic aspects concerning the use of heparin and β‐cyclodextrin tetradecasulfate for the treatment of vascular restenosis Drug Development Research ·Christopher Reilly, Tsuneo Fujita, Rosemary C. McFall, Inez I. Stabilito, Waisi Eng, Robert G. Johnson	1993	10
14	Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells Journal of Biological Chemistry ·Christopher Reilly, Rosemary C. McFall	1991	117
15	Cell-mediated immunity in herpes corneal stromal disease. PubMed ·Rose Marie Nagy, Rosemary C. McFall, T W Sery	1980	5
16	Scanning electron microscopic observation of two retinoblastoma cell lines. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Rosemary C. McFall, Rose Marie Nagy, Barbara T. Nagle, Lolly M. McGreevy	1978	19
17	Aqueous humor enzyme patterns in retinoblastoma. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Norman T. Felberg, Rosemary C. McFall, Jerry A. Shields	1977	20
18	Characterization of a new continuous cell line derived from a human retinoblastoma. PubMed ·Rosemary C. McFall, Theodore W. Sery, Marcia Makadon	1977	184
19	The WIRL-3 rat liver cell lines and their transformed derivatives. PubMed ·Leila Diamond, Rosemary C. McFall, Yutaka Tashiro, David M. Sabatini	1973	51
20	The effects of two isomeric benzoflavones on aryl hydrocarbon hydroxylase and the toxicity and carcinogenicity of polycyclic hydrocarbons. PubMed ·Leila Diamond, Rosemary C. McFall, J. A. Miller, Harry V. Gelboin	1972	29

About Rosemary C. McFall

Rosemary C. McFall is a scholar working on Oncology, Cancer Research, Toxicology, Hepatology and Ophthalmology, having authored 23 papers that have together received 880 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), HER2/EGFR in Cancer Research (7 papers), Angiogenesis and VEGF in Cancer (5 papers), Quinazolinone synthesis and applications (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Virus-based gene therapy research (2 papers), Renin-Angiotensin System Studies (2 papers) and Ocular Oncology and Treatments (2 papers). The work is most often cited by research in Ophthalmology (133 citations), Cancer Research (140 citations), Organic Chemistry (239 citations), Immunology and Allergy (50 citations) and Oncology (170 citations). Rosemary C. McFall has collaborated with scholars based in United States. Frequent co-authors include Christopher Reilly, Theodore W. Sery, Kathleen Coll, Kenneth A. Thomas, William F. Hoffman, William R. Huckle, Mark E. Fraley, Leila Diamond, Richard Kendall and Ruth Z. Rutledge. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Circulation, Molecular Cancer Therapeutics, British Journal of Ophthalmology and Current Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact